Patents by Inventor Jean Georges

Jean Georges has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Wireless messaging system to multiple recipients
    Publication number: 20020168965
    Abstract: A two way wireless hand held PDA device that allows remote mobile creation of messages and sending of those messages to recipients via different delivery modes. The recipients can be formed into groups by different criteria, the messages can be created or imported and edited from the remote device, and the messages can be delivered via more than one mode. Status of messages sent and in process is maintained as is account information related to the message and the user. Also messages can be formatted, and can be conditionally sent and receivers can perform automatic actions when specific messages are received. (And actions can be carried out in remote systems based on the responses to messages sent).
    Type: Application
    Filed: April 25, 2002
    Publication date: November 14, 2002
    Inventors: Keith Edward Gregory, Yola Keteline Jean-George, William Harry Kirtley, David A. Page, Howard Geza Page, Adrien Paul Raphael Schmidt, Gregory Charles Warden
  • 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
    Patent number: 6472382
    Abstract: A subject of the invention is the compounds of formula (I): in which X is a halogen atom, D represents the remainder of an optionally substituted pentagonal or hexagonal ring and optionally carrying an unsaturation, R1, R2, R3, R4, Y and n are as defined in the description, their preparation process and intermediates, their use as medicaments and the compositions containing them.
    Type: Grant
    Filed: December 8, 2000
    Date of Patent: October 29, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Yamina Bouali, Francois Nique, Jean-Georges Teutsch, Patrick Van De Velde
  • 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
    Patent number: 6462211
    Abstract: A subject of the invention is the compounds of formula (I): in which X is a halogen atom, D represents the remainder of an optionally substituted pentagonal or hexagonal ring and optionally carrying an unsaturation, R1, R2, R3, R4, Y and n are as defined in the description, their preparation process and intermediates, their use as medicaments and the compositions containing them.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: October 8, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Yamina Bouali, Francois Nique, Jean-Georges Teutsch, Patrick Van De Velde
  • Tricyclic compounds, their preparation process and the intermediates of this process, their use as medicaments and the pharmaceutical compositions containing them
    Patent number: 6459001
    Abstract: The subject of the invention is the products of formula (I): in which R1, R2, R3, R4, R5 and G are as defined in the description, the dotted lines represent an optional second bond, as well as the addition salts with acids and bases and the esters, their preparation process and the intermediates of this process, their use as medicines and the pharmaceutical compositions containing them.
    Type: Grant
    Filed: January 25, 2001
    Date of Patent: October 1, 2002
    Assignees: Aventis Pharma S.A., Genetech
    Inventors: Serge Bernard, Denis Carniato, Jean-Francois Gourvest, Jean-Georges Teutsch, Jochen Knolle, Hans-Ulrich Stilz, Volkmar Wehner, Sarah C. Bodary, Thomas R. Gadek, Robert S. McDowell, Robert M. Pitti
  • Method and system for providing time-shifted delivery of live media programs
    Publication number: 20020124258
    Abstract: Improved approaches for delivering media programs to viewers (e.g., subscribers) are disclosed. The media programs are typically broadcast in accordance with a schedule. The media program can be delivered to viewers through multicast or unicast. According to one aspect, the media programs are buffered (e.g., cached) in a data packet format such that producing unicasts for particular viewers requires less computation and resources such that more concurrent unicasts are able to be effectively supported.
    Type: Application
    Filed: March 1, 2001
    Publication date: September 5, 2002
    Applicant: Minerva Networks, Inc.
    Inventor: Jean-Georges Fritsch
  • New 19-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositions
    Publication number: 20020072624
    Abstract: Novel compounds having a formula selected from the group consisting of 1
    Type: Application
    Filed: June 26, 2001
    Publication date: June 13, 2002
    Applicant: Roussel Uclaf
    Inventors: Andre Claussner, Francois Nique, Jean-Georges Teutsch, Patrick Van De Velde
  • Biphenyl compounds and their use as oestrogenic agents
    Publication number: 20020068736
    Abstract: Novel intermediates of Formula IV wherein the substituents are as defined in the specification and a process for preparing the same.
    Type: Application
    Filed: June 29, 2001
    Publication date: June 6, 2002
    Inventors: Dominique Lesuisse, Jean-Georges Teutsch
  • 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
    Patent number: 6399766
    Abstract: A subject of the invention is the compounds of formula (I): in which X is a halogen atom, D represents the remainder of an optionally substituted pentagonal or hexagonal ring and optionally carrying an unsaturation, R1, R2, R3, R4, Y and n are as defined in the description, their preparation process and intermediates, their use as medicaments and the compositions containing them.
    Type: Grant
    Filed: January 10, 2001
    Date of Patent: June 4, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Yamina Bouali, Francois Nique, Jean-Georges Teutsch, Patrick Van De Velde
  • 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
    Publication number: 20020040135
    Abstract: A subject of the invention is the compounds of formula (I): 1
    Type: Application
    Filed: December 22, 2000
    Publication date: April 4, 2002
    Inventors: Yamina Bouali, Francois Nique, Jean-Georges Teutsch, Patrick Van De Velde
  • Steroids, their use as medicaments, their preparation process, the intermediates of this process and the compositions containing them
    Publication number: 20020002155
    Abstract: The subject of the invention is the products of formula (I): 1
    Type: Application
    Filed: June 25, 2001
    Publication date: January 3, 2002
    Applicant: Hoechst Marion Roussel
    Inventors: Neerja Bhatnagar, Andre Claussner, Christian Marchandeau, Michele Resche Rigon, Jean-Georges Teutsch
  • New 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
    Publication number: 20010039268
    Abstract: A subject of the invention is the compounds of formula (I): 1
    Type: Application
    Filed: December 8, 2000
    Publication date: November 8, 2001
    Applicant: Hoechst Marion Roussel
    Inventors: Yamina Bouali, Francois Nique, Jean-Georges Teutsch, Patrick Van De Velde
  • Neuron promoter and uses
    Patent number: 6309876
    Abstract: The present invention relates to a DNA expression vector comprising a T&agr;l &agr;-tubulin promoter operatively linked upstream to a marker gene sequence relative to the direction of transcription in a eukaryotic expression vector adapted to be introduced into a mammal, or ancestor of the mammal at an embryonic stage and the promoter is controlling transcription of the marker gene. The present invention also relates to a method for testing material suspected of promoting neurogenesis and neuronal growth which comprises exposing a transgenic mammal according to the present invention to the material and detecting the expressed marker gene as an indication of neurogenesis and neuronal growth.
    Type: Grant
    Filed: December 14, 1999
    Date of Patent: October 30, 2001
    Assignee: McGill University
    Inventors: Freda Diane Miller, Andrew Gloster, Carrie Grace Causing, Jean George Toma
  • Biphenyl compounds and use thereof as oestrogenic agents
    Patent number: 6288126
    Abstract: A compound having the formula wherein R5 is an [A]—CH3, —[A]—C(OH)ZZ′ or —[A]—C(O)Z″ grouping where —[A]— is an alkylene, alkenylene or alkynylene radical or a single bond, and Z, Z′ and Z″ are a hydrogen atom or an optionally substituted alkyl, alkenyl, alkynyl or aryl radical; and R1, R2, R3, R4, R6, R7 and R8 are as defined in the description; the use thereof as a drug, pharmaceutical compositions containing same, a preparation method therefor, and intermediates of said method, are disclosed.
    Type: Grant
    Filed: September 28, 1998
    Date of Patent: September 11, 2001
    Assignee: Aventis Pharma S.A.
    Inventors: Dominique Lesuisse, Jean-Georges Teutsch
  • 19-nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, and the intermediates of this process, their use as medicaments and compositions
    Patent number: 6281204
    Abstract: Compounds of formula (I), wherein R17 and R′17 are such that: either R17 and R′17 together form ketone, hydrazono, oxime or methylene, or R17 is hydroxyl, hydroxymethyl or acyloxy and R′17 is hydrogen, alkyl or optionally substitued alkenyl or alkynyl; R3 is hydrogen or alkyl; R16 is hydrogen, halogen or alkyl; m is 0, 1 or 2; X, Y and Z are such that: X is methylene, arylene or arylenoxy bonded to the steroid by a carbon atom; Y is a saturated or unsaturated straight or branched aliphatic chain which is optionally interrupted by oxygen; and Z is aryl, arylalkyl or straight or branched alkyl; addition salts thereof, a preparation method therefor, medicinal uses thereof, compositions containing said compounds, and resulting novel intermediates.
    Type: Grant
    Filed: June 9, 1994
    Date of Patent: August 28, 2001
    Inventors: Andre Claussner, Francois Nique, Jean-Georges Teutsch, Patrick Van De Velde
  • Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
    Patent number: 6274572
    Abstract: The subject of the invention is the products of formula (I): in which either R1 represents halogen, hydroxyl, (C1-C8) alkyloxy or (C1-C12) acyloxy, and R2 represents halogen or hydrogen, or R1 and R2 form together a double bond, Z is chosen from optionally substituted (C1-C8) alkylthio, optionally substituted arylthio, (C1-C8) alkyloxy, halogen, cyano, mercapto, thiocyanato and (CH2)0-1—CO2H, optionally esterified, Y represents hydrogen or methyl, the dotted line in position 1-2 or 5-6 optionally representing a second bond, as well as their addition salts, their preparation process, the intermediates of this process and the pharmaceutical compositions containing them.
    Type: Grant
    Filed: December 21, 1998
    Date of Patent: August 14, 2001
    Assignee: Aventis Pharma S.A.
    Inventors: Neerja Bhatnagar, Andre Claussner, Christian Marchandeau, Michele Resche Rigon, Jean-Georges Teutsch
  • New 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
    Publication number: 20010008941
    Abstract: A subject of the invention is the compounds of formula (I): 1
    Type: Application
    Filed: January 10, 2001
    Publication date: July 19, 2001
    Applicant: Hoechst Marion Roussel
    Inventors: Yamina Bouali, Francois Nique, Jean-Georges Teutsch, Patrick Van De Velde
  • New 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
    Publication number: 20010005756
    Abstract: A subject of the invention is the compounds of formula (I): 1
    Type: Application
    Filed: January 10, 2001
    Publication date: June 28, 2001
    Applicant: Hoechst Marion Roussel
    Inventors: Yamina Bouali, Francois Nique, Jean-Georges Teutsch, Patrick Van De Velde
  • Phenylimidazolidines containing nitrooxy or carbonyloxy groups
    Patent number: 6242611
    Abstract: A subject of the invention is the products of formula (I): in which: R1 and R2 represent in particular cyano and trifluoromethyl, R3 represents in particular alkyl, alkenyl or alkynyl, substituted in particular by nitrooxy or carbonyloxy, R4 and R5 represent in particular methyl optionally substituted by fluorine, X and Y represent in particular oxygen, as well as their salts and isomers.
    Type: Grant
    Filed: September 28, 1998
    Date of Patent: June 5, 2001
    Assignee: Hoechst Marion Roussel
    Inventors: Andre Claussner, Francois Goubet, Jean-Georges Teutsch
  • 4- Halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same
    Patent number: 6239121
    Abstract: A subject of the invention is the compounds of formula (I): in which X is a halogen atom, D represents the remainder of an optionally substituted pentagonal or hexagonal ring and optionally carrying an unsaturation, R1, R2, R3, R4, Y and n are as defined in the description, their preparation process and intermediates, their use as medicaments and the compositions containing them.
    Type: Grant
    Filed: November 29, 1999
    Date of Patent: May 29, 2001
    Assignee: Hoechst Marion Roussel
    Inventors: Yamina Bouali, Francois Nique, Jean-Georges Teutsch, Patrick Van De Velde
  • Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same
    Patent number: 6221907
    Abstract: The subject of the invention is the products of formula (I): in which R1, R2, R3, R4, R5 and G are as defined in the description, the dotted lines represent an optional second bond, as well as the addition salts with acids and bases and the esters, their preparation process and the intermediates of this process, their use as medicines and the pharmaceutical compositions containing them.
    Type: Grant
    Filed: February 2, 1999
    Date of Patent: April 24, 2001
    Assignee: Hoechst Marion Roussel
    Inventors: Serge Bernard, Denis Carniato, Jean-Francois Gourvest, Jean-Georges Teutsch, Jochen Knolle, Hans-Ulrich Stilz, Volkmar Wehner, Sarah C. Bodary, Thomas R. Gadek, Robert S. McDowell, Robert M. Pitti